Precigen, Inc. (PGEN)
3.52
-0.17
(-4.61%)
USD |
NASDAQ |
Dec 09, 16:00
3.50
-0.02
(-0.57%)
After-Hours: 18:01
Precigen Shareholders Equity (Quarterly): 41.87M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Omeros Corp. | -220.48M |
| GeoVax Labs, Inc. | 4.907M |
| Vistagen Therapeutics, Inc. | 66.34M |
| ADMA Biologics, Inc. | 431.19M |
| Daré Bioscience, Inc. | 2.858M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 171.26M |
| Total Liabilities (Quarterly) | 129.40M |
| Debt to Equity Ratio | 2.345 |
| Current Ratio | 4.041 |
| Net Debt Paydown Yield | -1.58% |